Product
AR-14034
Aliases
AR-14034 SR implant lower dose
1 clinical trial
1 indication
Clinical trial
A Phase 1/2 Two-Stage Dose Escalation and Randomized Parallel-Group Study to Evaluate the Safety, Preliminary Treatment Effects, and Durability of AR-14034 Sustained Release Implant Compared to Intravitreal Anti-Vascular Endothelial Growth Factor Treatment in Participants With Neovascular Age-Related Macular DegenerationStatus: Recruiting, Estimated PCD: 2027-02-01